Skip to content

Clinical study to see the effect of Ayurvedic preparations on Sarvasara Mukharoga.

A Randomized Comparetive Clinical Study On The Efficacy Of Patoladi Kwatha and Triphaladi Kwatha In The Manegement Of Sarvasara Mukharoga W.S.R. to Oral Submucus Fibrosis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056298
Enrollment
30
Registered
2023-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis Health Condition 2: K135- Oral submucous fibrosis

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 18-60 years of patients. 2. The patients having clinical signs and symptoms of Sarvasara Mukharoga. 3. Patients of either sex will be selected randomly.

Exclusion criteria

Exclusion criteria: 1. Extensive fibrosis by means of severe trismus with an Inter incisal distance (IID) of less than15 mm. 2. Disease is most advanced with pre-malignant and malignant changes. 3. Generalized fibromatosis. 4. Oral manifestation of scleroderma. 5. Oral lichen planus. 6. Chronic debilitating condition such as DM, Uncontrolled HT, HIV, etc. 7. Individuals above 60 years and below 18 years of age of either sex. 8. Patients not willing to give up addiction habits of Gutka, pan masala, tobacco, etc.

Design outcomes

Primary

MeasureTime frame
Change in inter incisial distance (in mm).Timepoint: at baseline day and after completion of trial

Secondary

MeasureTime frame
.Change in quality of life. 2.Change in symptoms like pain, burning sensation and intolerance to spicy food.Timepoint: at baseline day and after completion of trial

Countries

India

Contacts

Public ContactDr Gulab Chand Pamnani

National Institute of Ayurveda Jaipur RAJASTHAN 302002 India

pamnani.gulab@gmail.com9461154942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026